The network of pluripotency, epithelial–mesenchymal transition, and prognosis of breast cancer
Ioannis A Voutsadakis1,2 1Division of Medical Oncology, Department of Internal Medicine, Sault Area Hospital, Sault Ste Marie, ON, Canada; 2Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury, ON, Canada Abstract: Breast cancer is the leading female cancer in terms of prevale...
Enregistré dans:
Auteur principal: | Voutsadakis IA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2c2b3aa47d8e4461bab26e2d7edc96c9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
par: Guangyu Wang, et autres
Publié: (2021) -
Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
par: Zielinska HA, et autres
Publié: (2015) -
Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
par: Tao Qin, et autres
Publié: (2021) -
Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer
par: Seguin C, et autres
Publié: (2017) -
Emerging role of brain metastases in the prognosis of breast cancer patients
par: Hambrecht A, et autres
Publié: (2011)